Glenmark Pharmaceuticals, INC., USA
Leading,integrated, research-driven, global pharmaceutical manufacturing company.
Based in NJ
🤖
AI Overview
With $980K in lobbying spend across 20 quarterly filings, Glenmark Pharmaceuticals, INC., USA is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2022.
$980K
Total Spend
5
Years Active
1
Firms Hired
7
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $250K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $130K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent
- •General education about the generic pharmaceutical industry.
- •Issues related to Medicaid CPI Penalty.
- •General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.